Sagent Pharmaceuticals, Inc. 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 24, 2014
Insider Transaction Report
Form 4
Drake Lorin
VP, Sales and Marketing
Transactions
- Tax Payment
Common Stock
2014-02-21$21.84/sh−388$8,474→ 25,703 total - Tax Payment
Common Stock
2014-02-22$21.75/sh−290$6,308→ 25,413 total